Rangatira Annual Report 2023 - Flipbook - Page 25
Ra n g a t i ra An n u a l Re p ort 2023
Bio-Strategy
Bio-Strategy is a specialist distributor of laboratory
instruments and automation technology products for the
clinical diagnostic, life science and applied sectors. Their
highly trained staff provide a range of sales and support for
customers in laboratories, academia, hospitals, and industry.
Bio-Strategy represents over 150 international agencies
with 120 staff across 7 offices in New Zealand and Australia.
Medical devices continue to enjoy consistent demand and
the business continues to actively seek additional growth
opportunities, both additional distribution agreements as
well as acquisitions.
Investment Date
2015
Ownership Interest
70%
Boulcott Hospital
Boulcott Hospital is a private surgical hospital based in
Lower Hutt, with 30+ years’ experience providing quality
surgical and medical services.
Boulcott has 3 operating theatres, a 30-bed ward and
day stay unit, a specialist centre and Radiology services
provided by Pacific Radiology. Over 40 specialists work
from the hospital with disciplines including orthopaedics,
gynaecology, plastics, endoscopy, and general surgery.
Several of the specialists are shareholders in the hospital,
investing alongside Rangatira in 2022.
A significant expansion is planned for 2023/24 which will
modernise and add capacity to the hospital, positioning
Boulcott as a quality private hospital servicing the greater
Wellington Region.
Investment Date
2022
Ownership Interest
69%
25